Related Experiment Videos
Expression of hepatitis A virus capsid sequences in insect cells
S A Harmon1, J M Johnston, T Ziegelhoffer
1Department of Cellular, Viral and Molecular Biology, University of Utah, Salt Lake City.
Virus Research
|May 1, 1988
Summary
Scientists engineered a recombinant virus to produce hepatitis A virus (HAV) VP1 protein in insect cells. This expressed protein was recognized by antibodies, indicating its potential for diagnostic applications.
Area of Science:
- Molecular Biology
- Virology
- Biotechnology
Background:
- Hepatitis A virus (HAV) is a significant human pathogen.
- Production of viral proteins is crucial for diagnostic and vaccine development.
- Recombinant DNA technology offers a platform for expressing viral antigens.
Purpose of the Study:
- To express the hepatitis A virus (HAV) VP1 protein in insect cells using a baculovirus expression system.
- To characterize the expressed HAV VP1 protein and assess its antigenicity.
Main Methods:
- Insertion of a cDNA encoding HAV VP1 and flanking sequences into Autographa californica nuclear polyhedrosis virus (AcNPV) genome.
- Infection of insect cells with the recombinant baculovirus.
- Analysis of protein expression using SDS-PAGE and immunoblotting with specific antisera.
Main Results:
- High-level production of a 55 kDa protein containing HAV VP1 in infected insect cells.
- The expressed protein reacted with anti-VP1 serum, human convalescent HAV sera, and rabbit anti-HAV sera.
- The protein was localized predominantly in the cytoplasm, likely as an insoluble aggregate.
Conclusions:
- The baculovirus expression system can successfully produce antigenically active hepatitis A virus VP1 protein.
- The expressed protein holds potential for use in diagnostic assays for HAV infection.
- Further studies may explore the solubility and purification of the expressed protein for broader applications.